Today, the department released the memorandum for Force Health Protection Guidance (Supplement 15) Revision 1 – Department of Defense Guidance for Coronavirus Disease 2019 Laboratory Testing Services. This memorandum updates previous DoD coronavirus disease 2019 (COVID-19) laboratory testing guidance and rescinds and replaces Under Secretary of Defense for Personnel and Readiness Memorandum, “Force Health Protection Guidance (Supplement 15) -Department of Defense Guidance for Coronavirus Disease 2019 Clinical Laboratory Testing Services,” January 11, 2021.
This force health protection (FHP) supplement provides guidance on COVID-19 testing for eligible persons suspected of having contracted COVID-19, and applies Centers for Disease Control and Prevention (CDC) testing guidance in the DoD context. DoD Components will continue to employ clinical diagnostic testing1 in accordance with this guidance. This guidance also supports surveillance testing and screening testing (asymptomatic individuals) conducted to decrease operational risk within DoD, consistent with applicable law and in accordance with Under Secretary of